Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Journal of Medicinal Chemistry
|
September 16, 2005
A new pyridazine series of GABAA alpha5 ligands
Monique B van Niel, Kevin Wilson, Charles H Adkins, et al.
Gastro Hep Advances
|
August 12, 2024
Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma
Stefanie S Schalm, Erin O'Hearn, Kevin Wilson, et al.
Frontiers in Human Neuroscience
|
October 31, 2022
Transcranial direct current stimulation modulates working memory and prefrontal-insula connectivity after mild-moderate traumatic brain injury
Davin K Quinn, Jacqueline Story-Remer, Emma Brandt, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2009
Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2)
Richard W Heidebrecht, Melissa Chenard, Joshua Close, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 6, 2026
Balance Versus Bias: Correcting Misinformation About the 2025 ATS Community-Acquired Pneumonia Guidelines
Julio A Ramirez, Barbara E Jones, Eyal Oren, et al.
The Journal of Infection
|
October 4, 2025
Prevalence and impact of SARS-CoV-2, influenza, respiratory syncytial virus (RSV) infection and respiratory illness on UK healthcare workers during winter 2023/24 (September 2023 to March 2024): SIREN cohort study
Sarah Foulkes, Katie Munro, Dominic Sparkes, et al.
Science Translational Medicine
|
November 3, 2017
A precision therapy against cancers driven by <i>KIT/PDGFRA</i> mutations
Erica K Evans, Alexandra K Gardino, Joseph L Kim, et al.
Journal of Medicinal Chemistry
|
July 15, 2022
Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer
Meredith S Eno, Jason D Brubaker, John E Campbell, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor
Joey L Methot, Dawn Mampreian Hoffman, David J Witter, et al.
Journal of Medicinal Chemistry
|
April 16, 2019
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved Tolerability
Joey L Methot, Hua Zhou, Sam D Kattar, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Journal of Medicinal Chemistry
|
September 16, 2005
A new pyridazine series of GABAA alpha5 ligands
Monique B van Niel, Kevin Wilson, Charles H Adkins, et al.
Gastro Hep Advances
|
August 12, 2024
Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma
Stefanie S Schalm, Erin O'Hearn, Kevin Wilson, et al.
Frontiers in Human Neuroscience
|
October 31, 2022
Transcranial direct current stimulation modulates working memory and prefrontal-insula connectivity after mild-moderate traumatic brain injury
Davin K Quinn, Jacqueline Story-Remer, Emma Brandt, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2009
Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2)
Richard W Heidebrecht, Melissa Chenard, Joshua Close, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 6, 2026
Balance Versus Bias: Correcting Misinformation About the 2025 ATS Community-Acquired Pneumonia Guidelines
Julio A Ramirez, Barbara E Jones, Eyal Oren, et al.
The Journal of Infection
|
October 4, 2025
Prevalence and impact of SARS-CoV-2, influenza, respiratory syncytial virus (RSV) infection and respiratory illness on UK healthcare workers during winter 2023/24 (September 2023 to March 2024): SIREN cohort study
Sarah Foulkes, Katie Munro, Dominic Sparkes, et al.
Science Translational Medicine
|
November 3, 2017
A precision therapy against cancers driven by <i>KIT/PDGFRA</i> mutations
Erica K Evans, Alexandra K Gardino, Joseph L Kim, et al.
Journal of Medicinal Chemistry
|
July 15, 2022
Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer
Meredith S Eno, Jason D Brubaker, John E Campbell, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor
Joey L Methot, Dawn Mampreian Hoffman, David J Witter, et al.
Journal of Medicinal Chemistry
|
April 16, 2019
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved Tolerability
Joey L Methot, Hua Zhou, Sam D Kattar, et al.
Page
of 9